SAB Biotherapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of SAB Biotherapeutics shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in SAB Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including SAB Biotherapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in SAB Biotherapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $202 | 294 | 0.69 |
| 2023-09-30 | $169 | 268 | 0.63 |
| 2023-06-30 | $205 | 247 | 0.83 |
| 2022-12-31 | $109 | 185 | 0.59 |
| 2022-09-30 | $0 | 180 | 0.00 |
| 2022-06-30 | $0 | 167 | 0.00 |